Results 171 to 180 of about 620,532 (331)

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Validation of markers for resistance to Pyrenophora teres f. teres loci on barley chromosomes 3H, 4H, and 6H in the polygenic inheritance of the trait. [PDF]

Vavilovskii Zhurnal Genet Selektsii
Afanasenko OS, Mironenko NV, Lashina NM, Rozanova IV, Kyrova EI, Nikolskaya YS, Zubkovich AA.   +6 more
europepmc   +1 more source

Genome-Wide Mapping of Growth-Related Quantitative Trait Loci in Orange-Spotted Grouper (Epinephelus coioides) Using Double Digest Restriction-Site Associated DNA Sequencing (ddRADseq) [PDF]

, 2016
Hui Yu, Xinxin You, Jia Li, Hankui Liu, Zining Meng, Ling Xiao, Haifa Zhang, Haoran Lin, Yong Zhang, Qiong Shi   +9 more
openalex   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

False-positive troponin in a professional cyclist: a case report on avoiding misdiagnosis and unnecessary restrictions. [PDF]

Eur Heart J Case Rep
Popelier C, Koppens K, L'Hoyes W, Lambrecht A, Van Puyvelde T.   +4 more
europepmc   +1 more source

Restriction Fragment Length Polymorphism and Gene Mapping of Two Genes Associated with Milk Composition in Egyptian River Buffalo* [PDF]

, 2010
Othman E. Othman
openalex   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

The application of DNA markers in population genetics of mosquitoes: a comprehensive review. [PDF]

Front Insect Sci
Wei Y, Wei Y, He S.
europepmc   +1 more source

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

Molecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex Michael Tamburino, Xin Yu, Aleksandra Katarzyna Olow   +10 more
wiley   +1 more source

Next-Generation Genotyping: Innovations Driving Plant Genomic Improvement. [PDF]

Life (Basel)
Kostyukova V, Kenzhebekova R, Protsenko E, Dulat B, Khusnitdinova M, Gritsenko D.   +5 more
europepmc   +1 more source